CODA Biotherapeutics, Inc. SBIR Phase I Award, September 2020
A SBIR Phase I contract was awarded to CODA Biotherapeutics in September, 2020 for $497,177.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Name
# Contributions
Last Contribution
Find more entities like CODA Biotherapeutics, Inc. SBIR Phase I Award, September 2020
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
